Banco Popular Espa?ol S.A.

  • ID: 1713319
  • January 2008
  • Standard & Poors
1 of 3

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Strong, above-average profitability track record Sound asset quality throughout a complete economic cycle Coherent, focused, and sound strategy High, albeit below the system's average, exposure to real estate developers Higher reliance than peers on wholesale funding More limited degree of business and geographic diversification than other 'AA' rated European banks The ratings on Banco Popular Espa-ol S.A. reflect strong financial fundamentals--in particular its solid earnings record and asset quality--and management's coherent, focused, and sound strategy. These factors offset Popular's higher-than-average reliance on wholesale funding, and more limited business and geographic diversification than for similarly rated peers. The bank's high exposure to the real estate developer segment represents the main downside risk for the ratings. Popular's strong profitability track record remains...

Companies mentioned in this report are: Banco Popular Espanol, S.A.
Action: Review

Note: Product cover images may vary from those shown
2 of 3

Banco Popular Espanol, S.A.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.